Please assess the completion status of the following clinical trial:

Trial Title: Automated Oxygen Titration with O2matic Home Oxygen Therapy (O2matic HOT) Phase 1

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Verified COPD with FEV1/FVC \< 0.70~* Need of LTOT (PaO2 \<= 7.3 kPa or SpO2 \< 88 % on ambient air)~* Cognitively able to participate~* Willing to provide informed consent~Exclusion Criteria:~* Moderate or severe exacerbation in COPD within 4 weeks from study start~* Major comorbidities (cancer, uncontrolled chronic disease)~* Asthma or other disease with need of higher SpO2~* Pregnancy~* Fall in pH below 7.35 or increase in PaCO2 \> 1 kPa on 5 liters of oxygen~* Active smoking~* LTOT use less than 1 hours/day

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Manual (Type: ACTIVE_COMPARATOR): Fixed dose oxygen
- O2matic (Type: EXPERIMENTAL): Automated oxygen titration

Based on this trial design, predict the completion outcome and termination type (if applicable).